classical hodgkin lymphoma

Showing 26 - 41 of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)

Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
Jun 29, 2021

B-CD30 + Hodgkin Lymphoma International Multi-center

Completed
  • Classical Hodgkin Lymphoma
  • Relapsed or Refractory Classical Hodgkin Lymphoma
    • Busan, Korea, Republic of
      Pusan National University Hospital
    Jun 3, 2021

    Classical Hodgkin Lymphoma Trial in Worldwide (cyclophosphamide, vincristine, prednisone, dacarbazine, cyclo, vcr, pred,

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • cyclophosphamide, vincristine, prednisone, dacarbazine
    • cyclo, vcr, pred, dacarb,etop and doxo
    • Victoria Park, Australia
    • +18 more
    May 10, 2021

    Classical Hodgkin Lymphoma Trial in Atlanta, Columbus (drug, other, biological)

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • Atlanta, Georgia
    • +1 more
    Mar 23, 2021

    Classical Hodgkin Lymphoma Trial in Belgium, France (Bendamustine, Prednisone, Vinblastine)

    Completed
    • Classical Hodgkin Lymphoma
    • Bruges, Belgium
    • +39 more
    Feb 18, 2021

    Classical Hodgkin Lymphoma Trial in Nanjing (Camrelizumab, Investigator's choice of Chemotherapy)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Feb 4, 2021

    Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Dec 29, 2020

    Classical Hodgkin Lymphoma Trial in Cologne (Brentuximab Vedotin)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Brentuximab Vedotin
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Nov 26, 2020

    Classical Hodgkin Lymphoma Trial in Chicago, Detroit, Seattle (Tenalisib, Pembrolizumab)

    Terminated
    • Classical Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Dec 24, 2019

    Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,

    Unknown status
    • Classical Hodgkin Lymphoma
    • +3 more
    • Riyadh, Saudi Arabia
      King Abdulaziz Medical City, Ministry of National Guard
    Nov 14, 2019

    CLASSICAL HODGKIN LYMPHOMA Trial in Spain (Brentuximab Vedotin, Etoposide, Soludomerin)

    Completed
    • CLASSICAL HODGKIN LYMPHOMA
    • Brentuximab Vedotin
    • +4 more
    • Oviedo, Asturias, Spain
    • +13 more
    Apr 23, 2019

    Classical Hodgkin Lymphoma Trial in Rouen (Digital Polymerase Chain Reaction)

    Unknown status
    • Classical Hodgkin Lymphoma
    • Digital Polymerase Chain Reaction
    • Rouen, France
      Centre Henri Becquerel
    Jul 20, 2018

    Classical Hodgkin Lymphoma Trial (KL-A167)

    Unknown status
    • Classical Hodgkin Lymphoma
    • (no location specified)
    Jun 26, 2018

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial

    Withdrawn
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +3 more
    • Brentuximab Vedotin
    • +2 more
    • (no location specified)
    Jan 12, 2018

    Social Inequalities in Participation and Activity in Children

    Unknown status
    • Classical Hodgkin Lymphoma
      • (no location specified)
      Jun 20, 2016

      Classical Hodgkin Lymphoma, Nodular Sclerosis, Mixed Cellularity Trial in Haifa (interim therapy scintigraphy study gallium scan

      Completed
      • Classical Hodgkin Lymphoma
      • +4 more
      • interim therapy scintigraphy study gallium scan or PET/CT
      • "interim gallium or PET/CT"
      • Haifa, Israel
        Eldad Dann
      Mar 20, 2006